Answers are grounded in this paper and cite their sources.
The folding and collapse of individual polymer chains into single-chain polymer nanoparticles (SCPNs) is a versatile and emerging platform for biological applications such as diagnostics, imaging, and therapy, where components for two or more of these functions can be combined onto a single polymer carrier. Here, we prepare heterotelechelic polymers with three sets of separately addressable chemical handles at their α-terminus and ω-terminus, and along their backbone. As a model system, the α- and ω-termini are conjugated with a targeting ligand (folic acid or biotin) and therapeutic drug cargo (camptothecin), respectively, and the backbone is grafted with pendant fluorescent dye molecules, poly(ethylene glycol) oligomers, and benzene-1,3,5-tricarboxamide. These polymers fold in water to give fluorescent SCPNs, which are characterized with respect to their physical and photophysical properties. The latter reveals a relationship between polymer folding, quantum yield, and resistance to photobleaching. The SCPNs are then shown to be useful for immunolabeling of SK-BR-3 breast cancer cells and exhibit little or no acute cytotoxicity. This work demonstrates that SCPNs can be used as a viable platform for bioconjugation and cell labeling, helps establish a set of design criteria for optimizing future biological applications, and opens the door to the development of SCPNs for a broader range of theranostic applications.
No takes yet. Share an insight, caveat, or question.
Bajj et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: